Dynamic changes in circulating tumor DNA assessed by shallow whole-genome sequencing associate with clinical efficacy of checkpoint inhibitors in NSCLC. - Carbonell C; Frigola J; Pardo N; Callejo A; Iranzo P; Valdivia A; Priano I; Cedrés S; Martinez-Marti A; Navarro A; Lenza L; Soleda M; et al. (Molecular oncology, 2023)